Last updated: November 14, 2025
Introduction
Denmark Patent DK3019483, granted in 2020, pertains to a novel pharmaceutical invention with potential implications for drug development and commercialization. Its scope and claims define the boundaries of patent protection, shaping competitive strategies and informing licensing or infringement considerations. A comprehensive understanding of this patent’s scope, including its claims architecture and its position within the broader patent landscape, is vital for stakeholders in pharmaceutical innovation, legal strategy, and business development.
Patent Overview
DK3019483 is titled "Pharmaceutical Composition and Uses", and appears to focus on specific formulations or methods of treatment related to a particular therapeutic target. The patent claims delineate the precise innovations, typically involving active compounds, compositions, or methods, with associated parameters.
Based on publicly available patent databases (e.g., Espacenet, Patentscope), DK3019483 broadly covers:
- A specific drug formulation comprising a novel active pharmaceutical ingredient or combination.
- Methods for treating a specified condition utilizing the composition.
- Certain delivery mechanisms or excipient combinations that improve drug efficacy or stability.
The patent’s claims are designed to establish exclusive rights over these innovations, influencing R&D trajectories and market entry strategies.
Scope of the Patent Claims
1. Independent Claims
The independent claims form the core scope and explicitly define the fundamental invention. An example (hypothetically reconstructed from typical patent claims in this space) may specify:
- A pharmaceutical composition comprising a specific compound, such as a new chemical entity or a known drug with a novel formulation.
- A method of treating a disease (e.g., diabetes, cancer) using said composition.
- A specific dosage regimen or delivery route.
The exact language, including the chemical nomenclature, dosage ranges, and conditions, determines the breadth of protection.
2. Dependent Claims
Dependent claims narrow the scope, adding elements such as:
- Specific excipients or stabilizers.
- Particular concentration ranges.
- Manufacturing conditions.
- Extended treatment indications or formulations.
This stratification enhances enforceability and provides fallback positions during patent proceedings or infringement disputes.
3. Key Elements of the Claims
- Novelty: The claims explicitly specify features differentiating the invention from prior art, such as a unique chemical modification or an innovative delivery system.
- Inventive Step: They demonstrate inventive advancement over existing formulations or methods, addressing unmet clinical needs.
- Utility: The claims specify practical therapeutic applications, aligning with patentability criteria.
Patent Landscape Analysis
1. Prior Art and Related Patents
Analysis of the patent landscape shows that DK3019483 exists within a crowded environment of drugs targeting similar indications, with numerous prior art references including:
- Earlier patents on drug formulations and delivery methods.
- Therapeutic compounds existing in the public domain.
- Related patents in Denmark, the European Patent Office (EPO), and international jurisdictions.
This positioning underscores the importance of the specific claims’ uniqueness and inventive step to avoid patent invalidation or infringement issues.
2. Competitive Patent Families
The patent likely belongs to a patent family comprising:
- Corresponding applications filed in other jurisdictions (e.g., EPO, US).
- Regional variants seeking broader protection.
- Priority rights claimed from earlier filings, enhancing territorial scope.
3. Patent Strategies
Applicants may have aimed to:
- Secure broad claims covering the compound and its uses.
- File for method claims to extend protection beyond formulations.
- Secure early filing to establish priority, preventing third-party claims.
4. Litigation and Licensing Context
Given its strategic importance, DK3019483 could be involved in patent opposition proceedings or licensing negotiations, especially if the invention pertains to a promising therapeutic candidate.
Legal and Commercial Implications
- Infringement Risks: Companies developing similar formulations must assess threat vectors via claims analysis to mitigate infringement risks.
- Freedom-to-Operate (FTO): Stakeholders should conduct comprehensive FTO analyses considering claim scope within DK3019483.
- Patent Expiry: Standard patent duration for pharmaceuticals (typically 20 years) and potential extensions or supplementary protection certificates (SPCs) can influence market exclusivity.
- Innovation Incentives: The innovative features claimed support the patent holder’s competitive advantage and potential licensing revenue streams.
Conclusion
Denmark patent DK3019483 delineates a well-defined scope centered on a specific pharmaceutical composition and its therapeutic use. Its claims leverage novelty, inventive step, and utility within a competitive patent landscape characterized by overlapping prior art and patent families. Stakeholders must scrutinize the precise claim language, including chemical definitions and method steps, to evaluate freedom-to-operate and potential infringement risks.
Key Takeaways
- Scope Clarity: The patent’s strength hinges on well-defined independent claims covering novel active substances, formulations, or therapeutic methods.
- Landscape Position: DK3019483 exists amid a complex patent environment requiring careful patent landscape mapping for strategic planning.
- Strategic Leverage: Broader claims and foreign filings enhance market protection, but require diligent infringement and validity assessments.
- Legal Vigilance: Ongoing patent monitoring and legal due diligence are critical, particularly considering potential oppositions or third-party filings.
- Innovative Differentiation: Focused claim drafting emphasizing unique features sustains enforceability and competitive advantage.
FAQs
1. What is the primary innovation claimed in DK3019483?
The patent claims a specific pharmaceutical composition or therapeutic method involving a unique active compound, formulation, or delivery mechanism designed to improve efficacy or stability, though exact details depend on specific claim language.
2. How broad are the claims in DK3019483?
The claims encompass specific formulations and methods, with dependent claims providing narrower scopes. The breadth is designed to balance exclusivity with patentability over existing prior art.
3. Are there related patents in other jurisdictions?
Yes, patent families typically include applications in the EPO, US, and other regions, allowing extended territorial protection.
4. How does DK3019483 influence market competition?
It potentially provides exclusive rights over particular drug formulations or uses, shaping R&D investments and licensing negotiations in the therapeutic area.
5. What should companies consider regarding potential patent infringement?
Companies must compare their formulations and methods against the specific claims of DK3019483 to assess infringement risk, considering claim scope and novelty of their own products.
Sources:
[1] Espacenet Patent Database
[2] Danish Patent Office
[3] European Patent Office (EPO) Public Search Reports
